New analysis from the EARLY TAVR trial showed patients between the age of 65 and 70 years old derived the most benefits of a ...

In a registry of patients who underwent transcatheter aortic valve replacement, those who had single antiplatelet therapy ...

A trend toward higher mortality in women with PPM who received a self-expanding valves deserves more scrutiny, though.